The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.
Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...
Co announces that a per protocol interim safety review by an independent Data Safety Monitoring Board recommended that GTXI continue clinical development as planned with its two pivotal Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback